Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Omega Diagnostics Group Plc LSE:ODX London Ordinary Share GB00B1VCP282 ORD 4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -6.00 -11.32% 47.00 47.00 48.00 54.00 47.50 54.00 5,914,544 16:35:05
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 9.8 1.2 0.8 58.8 85

Omega Diagnostics Share Discussion Threads

Showing 16151 to 16172 of 18050 messages
Chat Pages: Latest  650  649  648  647  646  645  644  643  642  641  640  639  Older
DateSubjectAuthorDiscuss
29/10/2020
13:33
A rather nice new tweet direct from ODX - with a chart showing capacity increasing to 2m lateral flow tests per week by April: Https://twitter.com/OmegaDiagnostic/status/1321798576129908739/photo/1 "Omega Diagnostics @OmegaDiagnostic ยท 32m By end of 2020 we will have production capacity at our Alva site for 0.5m lateral flow tests a week to match expected demand: ✅ 200k tests a week min for AbC-19 Rapid Tests ✅ some CD4 test production ✅ the rest for Mologic antibody and antigen test production
rivaldo
29/10/2020
12:20
looks like someone has sold.
thehitman1
29/10/2020
12:15
We need a couple of institutions on board.i cant see the price doing much now until the next update which is now a few months away.
upomega
29/10/2020
12:04
Not sure if this has already been posted.https://www.heraldscotland.com/business_hq/18829396.omega-adds-staff-alva-hq-covid-test-production-gears/
xtrmntr
29/10/2020
11:54
The MM's must have quite a few shares to move...hopefully we will start to tick up this afternoon....
barrywhit
29/10/2020
09:24
walking it back up now
thehitman1
29/10/2020
09:21
lots of buys today.
thehitman1
29/10/2020
08:59
Link to the Investor Presentation in the tweet: https://twitter.com/InvestorMeetCo/status/1321534038490992641
barrywhit
29/10/2020
08:36
Looking further ahead, Mr Harbinson said staff numbers could double again to 200 if there is deemed to be sufficient demand for its test kits. Omega hopes to have further clarity on those demand levels by the end of this year. READ MORE: Omega confirms Covid-19 test order volumes “We are exploring how we might take production up to the order of two million tests per week,” he said. “If we were doing that I think we would be looking to mid-April as a timeframe.” Shares in AIM-listed Omega fell yesterday after the company revealed a 29 per cent drop in turnover for the first six months of the year. The expected decline in revenues to just less than £3.2m was driven by a 38% fall in its dominant food intolerance testing division, which suffered as global health priorities focused on the pandemic. As a result, earnings for the period – as calculated before interest, tax, depreciation and amortisation – will come in at a loss of approximately £1.3m. Mr Harbinson said there has since been a recovery in demand for food intolerance testing, with a rebound in orders coming from across Europe, the Middle East and Latin America. Sales in October are expected to be approximately 20% higher on the same period last year. READ MORE: Full launch this month as Omega gets Covid test approval Omega said it believes there are significant near-term opportunities for this business unit in China, where it is awaiting confirmation of regulatory approval of a self-test version of its Food Detective kit. The company is also looking to access the US market. Earlier this month, the UK Rapid Test Consortium (UK-RTC) of which Omega is a member announced the UK Government had placed its first order for one million rapid AbC-19 antibody tests, which detect whether an individual has been previously infected by the coronavirus. Omega will manufacture approximately 175,000 of the first one million tests, and will produce “not less” than 25% of the demand from total orders placed over the term of the Government supply agreement. The company is also working on a rapid antibody test with Bedfordshire-based Mologic, as well as a rapid antigen test to detect those currently infected by the coronavirus. Both are lateral flow tests – similar to a home pregnancy test – which produce immediate results at the point where the test is taken. READ MORE: Omega Diagnostics gets key clearance for HIV tests The Mologic antibody test is said to be gaining “early sales traction” that “provides confidence for performance in the second half of the year”. A prototype of the Mologic antigen test is currently in evaluation “in a number of healthcare settings”, with the results to date looking “promisingR21;. By contrast, the Mologic ELISA antibody test, which must be sent away to a lab to procure results, has failed to gain the levels of traction initially anticipated. Mr Harbinson said it appears to be getting “squeezed out” between similar lab tests from larger competitors that can run on much higher volume equipment, and a broader market preference for lateral flow tests that produce fast results. As a “mitigating strategy”, Omega is looking at whether to offer its ELISA test to healthcare practitioners in the UK, with the results processed at its laboratory in Littleport, Cambridgeshire. Elsewhere, the company has received a number of purchase orders from Uganda and Mozambique for its Visitect CD4 test to help manage the care of patients with HIV. These have been channelled through a supply agreement signed earlier this year with the Clinton Health Access Initiative. Omega will announce its half-year results on November 30. Its shares closed yesterday’s trading down 18.5p at 74p.
barrywhit
29/10/2020
08:30
Looks like some interesting stuff in this new article from Scotland - I've reached my free article limit, so maybe someone else could post the rest? Https://www.heraldscotland.com/business_hq/18829396.omega-adds-staff-alva-hq-covid-test-production-gears/ "3 hrs ago Omega adds staff at its Alva HQ as Covid test production gears up Omega Diagnostics has boosted headcount at its facility in Alva by more than two-thirds as the Scottish diagnostics specialist has geared up for mass production of Covid-19 testing kits. Speaking after the company released a trading update covering the six months to September 30, group finance director Kieron Harbinson said the Alva headquarters will be home to more than 100 employees from the start of next week. The increase from 60 in May follows a £1 million investment to increase its high-volume manufacturing capability, with current capacity of 200,000 tests per week set to rise to 500,000 by the end of December."
rivaldo
29/10/2020
08:20
everyone topping up today.
thehitman1
29/10/2020
08:18
Bought some more after yesterday's presentation
teamwork1
29/10/2020
07:41
https://www.theguardian.com/world/2020/oct/28/10-of-englands-population-could-be-tested-for-covid-19-every-week
coley15
29/10/2020
07:37
Impressively confident presentation - and great to hear that ODX are fully funded for the development of production capacity to 2m a week and more....
rivaldo
29/10/2020
07:18
Timmmmbeeeeeerrrr 0.2 placing at 8am
charle8888
29/10/2020
01:44
not idiots, shorters and the same individual.
thehitman1
29/10/2020
01:00
Hopefully they will last longer than spivs before them.
upomega
29/10/2020
00:25
We have a right Charlie just registered and turned up, another one for the filter box...
barrywhit
29/10/2020
00:25
“X KING OF TAJ MAHAL” 👑 Lolz Another fake account registered on 28th Oct, RASKAL SOB is that u ???? 😂
riz000
29/10/2020
00:04
Ur mum is ur sister and she was bum by me
charle8888
29/10/2020
00:02
“X KING OF TAJ MAHAL” 👑 UR DAD 😂 😆
riz000
28/10/2020
23:48
Who is riwzana khan here
charle8888
Chat Pages: Latest  650  649  648  647  646  645  644  643  642  641  640  639  Older
ADVFN Advertorial
Your Recent History
LSE
ODX
Omega Diag..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201124 21:01:20